Novartis/Genetech stifle PA drug
Hi, I just found out my 13-month old son has a peanut allergy. We found it out by accident when he was being evaluated because of some asthma that he had. Needless to say, I was quite shocked and saddened, as I understand this allergy can be quite serious, particularly in those who also have asthma.
After doing some online research, I came across an article in the Wall Street Journal from April 5th that I think everyone on this sight MUST read. It is about how two big drug companies -- Genentech and Novartis -- sued to keep an extremely promising drug ("TNX-109") that in human trials virtually cured peanut allergy, from the market because they were afraid it would compete with a drug they are now testing. They won in court, and now TNX-109 sits on a shelf, never to see the light of day - much less FDA approval. Here is the link to the article, [url="http://online.wsj.com/wsjgate?subURI=%2Farticle%2F0%2C%2CSB111265511632497703%2Demail%2C00%2Ehtml&nonsubURI=%2Farticle%5Femail%2F0%2C%2CSB111265511632497703%2DIJjeoNnlad4o5uqaXuGa6"]http://online.wsj.com/wsjgate?subURI=%2F...nlad4o5uqaXuGa6[/url] qGm4%2C00%2Ehtml.
What these companies have done -- keeping a life-saving drug from PA sufferers in order to protect their bottom lines -- is unconscionable. Can you imagine the public outcry if this had been done for a cancer or AIDs drug? I urge everyone to read this article and write to Genentech and Novartis (and your representatives - who can put pressure on the companies) expressing your outrage. Perhaps with our collective voices we can help revive the promise of TNX-109. Here are the e-mail addresses: [email][email protected][/email], [email][email protected][/email]